| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Internal Medicine (Drs. Mirsattari, Orr, and Ross), Pathology (Dr. Del Bigio), Pharmacology and Therapeutics (Dr. Power), University of Manitoba, Winnipeg; and the Departments of Clinical Neurosciences (Dr. Power) and Pathology (Dr. McKenna), University of Calgary, Alberta, Canada.
Address correspondence and reprint requests to Dr. Christopher Power, Department of Clinical Neuroscience, 3330 Hospital Drive NW, Calgary, Alberta, Canada, T2N 4N1; e-mail: power{at}ucalgary.ca
BACKGROUND: MS is common in people of northern European ethnicity who live in northern geographic areas; however, MS is rarely identified among aboriginal peoples living in the same areas.
OBJECTIVES: To determine the prevalence, clinical features, HLA type, and viral infections associated with MS among aboriginals in Manitoba, Canada.
METHODS: A retrospective study was performed in which the clinical features of all aboriginal patients with MS together with HLA type and human herpesvirus-6, HIV-1, human T-cell lymphotropic virus-1, and endogenous retrovirus associated with MS (MSRV) infections were analyzed and compared with results from nonaboriginal patients with MS.
RESULTS: Seven aboriginals with MS were identified with a period prevalence among aboriginals of 40:100,000. Clinical features included relapsing–remitting (n = 6) or primary progressive (n = 1) phenotypes with aggressive disease courses and frequent involvement of optic nerves and spinal cord (n = 5) compared with nonaboriginal patients. Autopsy of one patient showed necrosis and eosinophil infiltrates in a cervical spinal cord lesion and a demyelinated optic nerve. Analysis of HLA alleles at the DRB1 and DQB1 loci indicated that the HLA types detected were common in aboriginals, but there were no HLA alleles previously associated with the development of MS. Analysis of the copy number of MRSV did not show differences among aboriginals and nonaboriginals with or without MS.
CONCLUSIONS: Aboriginals of Algonkian background are at increased risk for an aggressive type of MS, resembling neuromyelitis optica, which is resistant to conventional MS treatments and occurs independently of HLA alleles previously associated with MS.
This article has been cited by other articles:
|
|
 |
|
  J. A Cabrera-Gomez, L Quevedo-Sotolongo, A Gonzalez-Quevedo, S Lima, Y Real-Gonzalez, M Cristofol-Corominas, K Romero-Garcia, C Ugarte-Sanchez, J Jordan-Gonzalez, J E G. de la Nuez, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica Multiple Sclerosis, March 1, 2007; 13(2): 186 - 192. [Abstract] [PDF]
|
|
|
|
|
|
S Sotgiu, G Arru, M Soderstrom, G Mameli, C Serra, and A Dolei Multiple sclerosis-associated retrovirus and optic neuritis Multiple Sclerosis, June 1, 2006; 12(3): 357 - 359. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Alter, E. Kahana, N. Zilber, A. Miller, and for the Israeli MS Study Group Multiple sclerosis frequency in Israel's diverse populations Neurology, April 11, 2006; 66(7): 1061 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Zehntner, C. Brickman, L. Bourbonniere, L. Remington, M. Caruso, and T. Owens Neutrophils That Infiltrate the Central Nervous System Regulate T Cell Responses J. Immunol., April 15, 2005; 174(8): 5124 - 5131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Lucchinetti, R. N. Mandler, D. McGavern, W. Bruck, G. Gleich, R. M. Ransohoff, C. Trebst, B. Weinshenker, D. Wingerchuk, J. E. Parisi, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica Brain, July 1, 2002; 125(7): 1450 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Rivera, J. A. Cabrera, S. Mirsattari, and C. Power Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica Neurology, September 11, 2001; 57(5): 937 - 938. [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
